ES8301967A1 - Procedimiento de preparar compuestos carbostirilicos. - Google Patents

Procedimiento de preparar compuestos carbostirilicos.

Info

Publication number
ES8301967A1
ES8301967A1 ES507545A ES507545A ES8301967A1 ES 8301967 A1 ES8301967 A1 ES 8301967A1 ES 507545 A ES507545 A ES 507545A ES 507545 A ES507545 A ES 507545A ES 8301967 A1 ES8301967 A1 ES 8301967A1
Authority
ES
Spain
Prior art keywords
same
pct
processes
compositions containing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507545A
Other languages
English (en)
Other versions
ES507545A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55159016A external-priority patent/JPS5782390A/ja
Priority claimed from JP55179950A external-priority patent/JPS57102888A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8301967A1 publication Critical patent/ES8301967A1/es
Publication of ES507545A0 publication Critical patent/ES507545A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

_(PROCEDIMIENTO DE PREPARAR COMPUESTOS CARBOSTIFILICOS ). SE HACE REACCIONAR EL COMPUESTO (II) CON EL COMPUESTO (III) CON LO QUE SE OBTIENE AL COMPUESTO (I). R ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR UN ALQUENILO INFERIOR, UN ALQUINILO O UN GRUPO FENILOALQUILO. R ES HIDROGENO, ALQUILO, ALCOXI, UN ATOMO DE HALOGENO O UN GRUPO DE HIDROXI. R ES HIDROGENO, UN GRUPO ALQUILO, HALOGENO, UN GRUPO NITROSO, UN GRUPO AMINO, UN GRUPO ALCANOILAMINO U OTROS. R Y R PUEDEN SER IGUALES O DIFERENTES REPRESENTANDO CADA UNO UN ATOMO DE HIDROGENO, HALOGENO, UN ALQUILO, UN GRUPO HIDROXI, ALCOXI O UN GRUPO NITRO.
ES507545A 1980-11-11 1981-11-11 Procedimiento de preparar compuestos carbostirilicos. Granted ES507545A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55159016A JPS5782390A (en) 1980-11-11 1980-11-11 Carbostyril derivative
JP55179950A JPS57102888A (en) 1980-12-18 1980-12-18 Carbostyril derivative

Publications (2)

Publication Number Publication Date
ES8301967A1 true ES8301967A1 (es) 1983-02-01
ES507545A0 ES507545A0 (es) 1983-02-01

Family

ID=26485945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507545A Granted ES507545A0 (es) 1980-11-11 1981-11-11 Procedimiento de preparar compuestos carbostirilicos.

Country Status (19)

Country Link
US (1) US4414390A (es)
EP (1) EP0052016B1 (es)
KR (1) KR880001657B1 (es)
AT (1) AT382376B (es)
AU (1) AU547586B2 (es)
CA (1) CA1164459A (es)
CH (1) CH653684A5 (es)
DE (1) DE3152512T1 (es)
DK (1) DK157193C (es)
ES (1) ES507545A0 (es)
FI (1) FI71145C (es)
IT (1) IT8149680A0 (es)
MX (1) MX6802E (es)
NO (1) NO157819C (es)
PH (1) PH17158A (es)
PT (1) PT73959B (es)
SE (1) SE440653B (es)
SU (1) SU1215621A3 (es)
WO (1) WO1982001706A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537889A (en) * 1982-12-27 1985-08-27 Eli Lilly And Company Inotropic agents
US4636502A (en) * 1982-12-27 1987-01-13 Eli Lilly And Company Methods of producing a positive inotropic effect or vasodilation by administration of 2-phenyl imidazo pyrimidines and pyrazines
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
US4533734A (en) * 1983-11-10 1985-08-06 Eli Lilly And Company Inotropic agents
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
ES8608874A1 (es) * 1984-05-29 1986-09-01 Pfizer Un procedimiento para la preparacion de una 2-(1h)-quinolona
US4721721A (en) * 1984-12-18 1988-01-26 Rorer Pharmaceutical Corporation 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
GB8619902D0 (en) * 1986-08-15 1986-09-24 Pfizer Ltd Quinolone cardiac stimulants
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
ATE210663T1 (de) * 1994-06-20 2001-12-15 Takeda Chemical Industries Ltd Kondensierte imidazolderivate, ihre herstellung und verwendung
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
TWI324151B (en) 2003-04-02 2010-05-01 Novartis Ag Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
WO2010032195A1 (en) * 2008-09-16 2010-03-25 Csir Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
ES2362894B1 (es) * 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
WO2016162318A1 (de) * 2015-04-08 2016-10-13 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte
WO2017019828A1 (en) 2015-07-30 2017-02-02 Bristol-Myers Squibb Company Aryl substituted bicyclic heteroaryl compounds
JP7058256B2 (ja) * 2016-07-14 2022-04-21 ブリストル－マイヤーズ スクイブ カンパニー 二環式ヘテロアリール置換化合物
ES2823127T3 (es) 2016-07-14 2021-05-06 Bristol Myers Squibb Co Compuestos tricíclicos de quinolina y azaquinolina sustituidos con heteroarilo como inhibidores de PAR4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473819A (en) * 1976-01-28 1977-05-18 Gallardo Antonio Sa Derivatives of imidazo 1,2-a pyridine
ES482438A0 (es) * 1978-07-18 1980-04-01 Hoechst Ag Procedimiento para la preparacion de nuevos derivados de 2-(4-aminopiperidino)-3,4-dihidroquinoleina.
ES482439A0 (es) * 1978-07-18 1980-04-01 Hoechst Ag Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina.
JPS5553284A (en) * 1978-10-12 1980-04-18 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative
GB2031404A (en) * 1978-10-17 1980-04-23 Yoshitomi Pharmaceutical Pyridazinone compounds

Also Published As

Publication number Publication date
NO157819B (no) 1988-02-15
DK157193B (da) 1989-11-20
IT8149680A0 (it) 1981-11-11
KR880001657B1 (ko) 1988-09-05
FI822471L (fi) 1982-07-12
WO1982001706A1 (en) 1982-05-27
CH653684A5 (fr) 1986-01-15
AU547586B2 (en) 1985-10-24
MX6802E (es) 1986-07-29
FI71145C (fi) 1986-11-24
SE8204237D0 (sv) 1982-07-08
SE8204237L (sv) 1982-07-08
FI822471A0 (fi) 1982-07-12
EP0052016B1 (en) 1984-09-05
KR830007644A (ko) 1983-11-04
CA1164459A (en) 1984-03-27
FI71145B (fi) 1986-08-14
AT382376B (de) 1987-02-25
PT73959B (en) 1983-04-18
DE3152512C2 (es) 1991-01-03
US4414390A (en) 1983-11-08
PT73959A (en) 1981-12-01
SU1215621A3 (ru) 1986-02-28
DK157193C (da) 1990-04-09
SE440653B (sv) 1985-08-12
NO157819C (no) 1988-05-25
ATA908381A (de) 1986-07-15
AU7808581A (en) 1982-06-07
ES507545A0 (es) 1983-02-01
DK307482A (da) 1982-07-08
EP0052016A1 (en) 1982-05-19
NO822391L (no) 1982-07-09
PH17158A (en) 1984-06-13
DE3152512T1 (de) 1982-11-18

Similar Documents

Publication Publication Date Title
ES8301967A1 (es) Procedimiento de preparar compuestos carbostirilicos.
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
HUT67924A (en) Fungicidal compositions containing 2-(substituted phenyl)-3-methoxy-propenecarboxylates as active ingredients, process for producing the active ingredients, and method for combatting fungi
ES8400737A1 (es) "un procedimiento para preparar derivados de nicotinamida".
CS314891A3 (en) Antimicrobial preparation, substituted derivatives of 2-cyclohexan-1-yl-amine and process for preparing thereof
ES8401035A1 (es) "metodo de preparar compuestos benzoheterociclicos".
HU9600299D0 (en) Substituted azadioxacycloalkenes, fungicidal compositions containing them, process for the preparation of the compounds and the fungicidal compositions and method for combating fungi
HUT41402A (en) Fungicide compositions containing azolyl-methyl-oxirane derivatives and process for preparing the active ingredients
ATE18765T1 (de) Pharmazeutische zusammenstellungen.
IL98133A0 (en) Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8307757A1 (es) "procedimiento para la preparacion de mandelonitrilos y derivados de acido mandelico".
ES8103051A1 (es) Un metodo de preparar nuevos derivados de pirazolina
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
IL71788A0 (en) Pyridazinones,processes for their preparation and pharmaceutical compositions containing the same
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
ES8501607A1 (es) Procedimiento para la obtencion de heterociclos nitrogenosos de 5 miembros
ES8304087A1 (es) "un metodo de preparar derivados de pirazolina".
GB1126002A (en) New basic ethers and process for preparing same
EP0112511A3 (en) New compounds, pharmaceutical preparations containing same and process for their preparation
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
ATE40948T1 (de) Pyridylalkylnitratverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES8609330A1 (es) Un procedimiento para preparar nuevos derivados de 1,3-dihi-dro-6-1-ciano-1-isopropil-n-fenetil-n-metil-omega-aminoal- quil-7--hidroxi-furo-(3,4-c)-piridina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301